DEA schedule
Is oxycodone and aspirin a controlled substance?
Federal schedule for oxycodone and aspirin from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Oxycodone and aspirin is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Oxycodone (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted oxycodone and aspirin?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 1 prescription listings from 1 labelers, all Schedule II |
| DEA controlled substances list | Oxycodone: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Oxycodone | 9143 | II | Yes | OxyContin; Percocet; Endocet; Roxicodone; Roxicet | Listed by name |
Oxycodone and Aspirin NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 42806-061 | Oxycodone and Aspirin | tablet | 4.8355 mg/1; 325 mg/1 | Epic Pharma, LLC | CII |
Questions
Is oxycodone and aspirin a controlled substance?
Yes. Oxycodone and aspirin is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Oxycodone (Schedule II).
Is oxycodone and aspirin a narcotic?
Yes. The DEA list marks oxycodone and aspirin as a narcotic (NARC = Y) and places it in Schedule II. Its FDA established pharmacologic class is Nonsteroidal Anti-inflammatory Drug and Opioid Agonist and Platelet Aggregation Inhibitor.
What schedule is oxycodone and aspirin?
Oxycodone and aspirin is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.